TABLE 1

Cumulative accumulation of lysozyme in kidneys (indicated by ¹²³I) within 24 h after subcutaneous or intravenous injections of 2 MBq of ¹²³I-TC-lysozyme combined with different doses of unlabeled lysozyme in healthy and Adriamycin-nephrotic rats

Data represent the mean ± S.E.M. for n = 4 in all cases. The extent of lysozyme accumulation was compared between subcutaneous and intravenous dose for healthy and diseased animals (^†p < 0.01) and between tracer dose of ¹²³I-TC-lysozyme alone and tracer dose combined with 100 or 500 mg/kg unlabeled lysozyme (* p < 0.05, ** p < 0.01, and *** p < 0.001).